Memorial Sloan Kettering Cancer Center researchers assessed patient satisfaction and preferences for telemedicine, finding that 45% of people with cancer preferred telemedicine, while 34% preferred office visits and 21% had no preference.
FDA has cleared the first at-home self-collection kit for HPV screening, removing significant obstacles to cervical cancer detection.
